EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Doxycycline Treatment of Mansonella perstans –Infected Individuals Affects Immune Cell Activation and Causes Long-term T-cell Polarization

Wilfred Aniagyei, Jonathan Kofi Adjei, Ernest Adankwah, Julia Seyfarth, Ertan Mayatepek, Daniel Antwi Berko, Samuel Asamoah Sakyi, Linda Batsa Debrah, Alexander Yaw Debrah, Achim Hoerauf, Dorcas O Owusu, Richard O Phillips und 1 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciac428 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Wilfred Aniagyei und 12 weiteren Autor:innen. Beteiligte Einrichtung: Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana. Hauptthemen laut MEDLINE: Mansonella, Mansonelliasis, T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Medical Research Council, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Doxycycline is used for treatment of Mansonella perstans infection. Immune modulatory effects of both M. perstans and doxycycline have been described but long-term implications on host immune response are not defined. Here we determined multiple immune parameters of M. perstans–infected individuals before and after doxycycline treatment to characterize doxycycline effects on host T-cell immunity.

Methods

Immune characterization of doxycycline-treated M. perstans–infected individuals was performed as part of an open-label randomized clinical trial. Immune cell population phenotyping by flow cytometry and functional in vitro T-cell assays were performed at baseline, 6 months, and “long term” (18–24 months) after treatment start. Treatment efficacy, based on peripheral blood microfilaria (mf) burden, was correlated with immune parameters and effects on immune response against concomitant Mycobacterium tuberculosis infection were determined.

Results

Immune population phenotyping indicated changes in functional T-cell responses after doxycycline treatment. Constitutive and superantigen-induced T-cell activation and polarization towards T-helper type (TH) 1 phenotype at baseline declined after doxycycline treatment, whereas low proportions of TH17 and TH1* cells at baseline increased significantly at follow-up. In accordance, long-term decline in antigen-specific TH1 responses against concomitant M. tuberculosis infection was seen. Notably, only TH17 and TH1* changes after 6 months and TH17 at baseline were negatively correlated with M. perstans microfilaria burden or reduction, whereas long-term changes were not associated with treatment efficacy.

Conclusions

We found long-term immune modulatory effects of doxycycline treatment leading to decreased constitutive T-cell activation, polarization towards TH17/TH1*, and impaired immune response against concomitant M. tuberculosis infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MansonellaMansonelliasisT-LymphocytesAnimalsDoxycyclineTreatment OutcomeHumans

Stichwörter der Autor:innen

Mansonella perstansMycobacterium tuberculosisT-cell polarizationdoxycycline

Substanzen

Doxycycline

Autor:innen und Institutionen

  • Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana.
  • Department of Medical Diagnostics, College of Health Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana.
  • Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.
  • Department of Molecular Medicine, School of Medicine and Dentistry, College of Health Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana.
  • Faculty of Allied Health Sciences of Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Institute of Medical Microbiology, Immunology and Parasitology, University Hospital of Bonn, Bonn, Germany.

Förderung

  • Medical Research Council
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Aniagyei, W., Adjei, J. K., Adankwah, E., Seyfarth, J., Mayatepek, E., Antwi Berko, D., Sakyi, S. A., Batsa Debrah, L., Debrah, A. Y., Hoerauf, A., Owusu, D. O., Phillips, R. O., & Jacobsen, M. (2023). Doxycycline Treatment of Mansonella perstans –Infected Individuals Affects Immune Cell Activation and Causes Long-term T-cell Polarization. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac428

Vancouver

Aniagyei W, Adjei JK, Adankwah E, Seyfarth J, Mayatepek E, Antwi Berko D, et al. Doxycycline Treatment of Mansonella perstans –Infected Individuals Affects Immune Cell Activation and Causes Long-term T-cell Polarization. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac428

BibTeX
@article{Aniagyei2023,
  author = {Aniagyei, Wilfred and Adjei, Jonathan Kofi and Adankwah, Ernest and Seyfarth, Julia and Mayatepek, Ertan and Antwi Berko, Daniel and Sakyi, Samuel Asamoah and Batsa Debrah, Linda and Debrah, Alexander Yaw and Hoerauf, Achim and Owusu, Dorcas O and Phillips, Richard O and Jacobsen, Marc},
  title = {Doxycycline Treatment of Mansonella perstans –Infected Individuals Affects Immune Cell Activation and Causes Long-term T-cell Polarization},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciac428}
}
Kostenlos starten →